Drugs and Research - Clinical Research Informer

Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research

Bio Pharma Dive

JANUARY 30, 2025

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.

FDA Approval

FDA Approval Doctors Doctor Drugs

Biopharma & medical devices cos view advanced infrastructure to propel manufacturing & new drug development

AuroBlog - Aurous Healthcare Clinical Trials blog

NOVEMBER 21, 2024

Critical infrastructure in biopharma and medical devices plays a vital role in enabling innovation, bolstering research and development, and ensuring the production of novel drugs and products. It ensures scalability, quality control, and regulatory compliance.

Manufacturing

Manufacturing Development Compliance Drugs

NIH funds research for three experimental ALS drugs

Bio Pharma Dive

OCTOBER 6, 2023

The funding, which is part of ACT for ALS, will support expanded access studies of drugs developed by Prilenia Therapeutics, Clene Nanomedicine and Rapa Therapeutics.

Drugs

Drugs Research Development

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

New research could ease concerns over suicide risk of obesity drugs

Bio Pharma Dive

SEPTEMBER 3, 2024

While results from two after-the-fact analyses were “reassuring,” outside experts urged “continued vigilance” to ensure GLP-1 drugs don’t worsen problems in people with preexisting mental health conditions.

Drugs

Drugs Research

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. From Research to Real-World Care 🌎 Understand how AI-driven advancements are shaping personalized treatments and patient outcomes.

Clinical Trials

Eisai hunts for next Alzheimer’s drug with new research pact

Bio Pharma Dive

APRIL 22, 2024

A collaboration with BioArctic will focus on a technology designed to more effectively deliver drugs in the brain, following similar efforts by Roche.

Drugs

Drugs Research

Odyssey recruits news investors to fund precision drug research

Bio Pharma Dive

OCTOBER 13, 2022

A $168 million Series B round brings Odyssey’s total funding to date near $400 million, helping the startup support a growing pipeline of cancer and immune disease drug candidates.

Drugs

Drugs Research

Upstream Bio, a richly funded startup, reveals its lead drug and research plans

Bio Pharma Dive

JUNE 2, 2022

Backed by $200 million in funding and led by biotech veteran Samantha Truex, Upstream is developing a clinical-stage inflammatory disease drug acquired from Astellas last year.

Drugs

Drugs Research Development

AltruBio lands up to $225M after shift to immune drug research

Bio Pharma Dive

MAY 21, 2024

Since pivoting from oncology, the startup has raised close to $300 million and advanced an ulcerative colitis drug into mid-stage testing.

Drugs

Drugs Research

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? This new guidance will clearly impact the clinical research field, but how? In this exclusive webinar, Dr. Ben Locwin will discuss the potential effects of this draft, along with the pharmacological and toxicological considerations for optimizing doses of prescription drugs.

Clinical Research

As ALS research booms, one treatment center finds itself in the spotlight

Bio Pharma Dive

DECEMBER 20, 2023

The Healey center is at the front of ALS research and care, earning acclaim from patients, doctors and scientists. Still, the complexities of the disease and of drug development have brought hard-felt losses.

Research

Research Doctors Doctor Scientist

Innovation in Autoimmune and Bone Health Research: Driving Progress for Better Patient Outcomes

Worldwide Clinical Trials

OCTOBER 14, 2024

Fortunately, advances in clinical research are providing hope for better treatments and outcomes. With the support of global networks like ours at Worldwide Clinical Trials (Worldwide), autoimmune and bone health research is accelerating, providing new solutions to patients around the world.

Research

Research Clinical Trials Clinical Trials Immune Response

Foundery, a new biotech venture firm, sets out to speed early immune drug research

Bio Pharma Dive

AUGUST 22, 2023

Billing itself as both a scientific and investment partner, Foundery aims to provide research grants and drug development support to researchers developing new immunotherapies.

Research

Research Drugs Development

The Great RIF(T): One FDA Division’s Destruction and What it Could Mean for Generic Drugs

FDA Law Blog

APRIL 8, 2025

As folks steeped in the world of generic drugs And Hatch-Waxman know, theres a lot that happens before FDA can take action on an ANDA. About one third of these PSGs are for complex products and many reflect what OGD and DPD learned about the science of equivalence from GDUFA-funded regulatory science research. 314.150(c).

Generic Drugs

Generic Drugs Drugs Bioequivalency Production

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management.

Clinical Trials

Innovating in Autoimmune and Bone Health Research: Driving Progress for Better Patient Outcomes

Worldwide Clinical Trials

OCTOBER 14, 2024

Fortunately, advances in clinical research are providing hope for better treatments and outcomes. With the support of global networks like ours at Worldwide Clinical Trials (Worldwide), autoimmune and bone health research is accelerating, providing new solutions to patients around the world.

Research

Research Clinical Trials Clinical Trials Immune Response

India takes centre-stage in clinical trials for HIV/AIDS drug

AuroBlog - Aurous Healthcare Clinical Trials blog

DECEMBER 5, 2024

India has taken centre-stage in clinical trials for HIV/AIDS drug as there are several ongoing clinical trials in India focused on advancing HIV treatment. These trials are investigating new drug candidates, therapies, and approaches to manage HIV more effectively and potentially cure it.

Clinical Trials

Clinical Trials Clinical Trials Trials Drugs

Biogen, Ionis shelve ALS drug following study failure

Bio Pharma Dive

MAY 16, 2024

While results indicated the drug works as intended, it didn’t have enough of an effect on a protein that’s become integral to many ALS research programs.

Drugs

Drugs Protein Research

World Psoriasis Day 2024: New Treatments and Research Trends

XTalks

OCTOBER 24, 2024

Trends in Psoriasis Research: Biologics, Biosimilars and New Therapies Recent innovations in biologics and biosimilars have transformed psoriasis care. Meanwhile, Innovent Biologics recently saw its New Drug Application (NDA) for picankibart, an IL-23p19 inhibitor, accepted by the Chinese National Medical Products Administration (NMPA).

Research

Research Dermatology Clinical Trials Clinical Trials

Biotechs reveal layoffs, research revamps in third quarter earnings

Bio Pharma Dive

NOVEMBER 16, 2022

Tricida, Harpoon, Freeline and three other small drug developers have this week announced plans to cut staff or to reprioritize their drug development.

Research

Research Development Drugs

CHARM Therapeutics secures funding for oncology drug discovery research

Pharmaceutical Technology

MAY 16, 2023

CHARM Therapeutics has received investment from NVIDIA’s venture investment arm, NVentures, for deep learning-enabled drug discovery research. Representing a major milestone for the company, the investment will enable CHARM to do further work on the research and development of new medicines for oncology.

Research

Research Drugs Development Medicine

Novo Nordisk partners with Microsoft for AI-driven drug discovery

Pharmaceutical Technology

SEPTEMBER 13, 2022

Novo Nordisk has signed a new strategic partnership with Microsoft to expedite the discovery and development of drugs leveraging big data and artificial intelligence (AI). The post Novo Nordisk partners with Microsoft for AI-driven drug discovery appeared first on Pharmaceutical Technology.

Drugs

Drugs Big Data Development Research

Understanding Challenges in Early Parkinson’s Research: Critical Insights from Dr. Tom Babic

Worldwide Clinical Trials

APRIL 8, 2025

In a recent webinar, Challenges of Drug Development in Early Parkinsons Disease , Tom Babic, MD, PhD , our Vice President of Scientific Solutions in Neuroscience, uses his 40+ years of experience to share invaluable insights into the current state and future directions of early Parkinsons disease (PD) research.

Research

Research Clinical Trials Clinical Trials Trials

Researchers at IISc find Pranlukast has potential applications for TB therapy

AuroBlog - Aurous Healthcare Clinical Trials blog

JUNE 3, 2024

Researchers at the Indian Institute of Science (IISc) have found that Pranlukast have the potential applications in tuberculosis (TB) therapy. The researchers are of the view that it could enhance the healing process of lung tissues infected with TB.

Research

Research Drugs Clinical Trials Clinical Trials

Cloud robotics labs are accelerating drug discovery and development

Pharmaceutical Technology

OCTOBER 28, 2022

Drug discovery and development is an incredibly expensive and time-consuming process, taking between 12 and 18 years, and costing on average between $2 billion and $3 billion. Robots can improve drug discovery and development. Remote-controlled robotic labs.

Development

Development Drugs Pharma Companies Life Science

FDA, in another test of its flexibility, agrees to review Biogen's closely watched ALS drug

Bio Pharma Dive

JULY 26, 2022

Known as tofersen, the drug failed in the main study being used to support its approval. But an apparent effect on a protein of interest in ALS research has Biogen convinced the treatment will pass muster with regulators.

Drugs

Drugs Protein Regulation Research

FTC, in unusual move, leads Sanofi to terminate a drug research deal

Bio Pharma Dive

DECEMBER 12, 2023

Just before clearing Pfizer’s buyout of Seagen, the regulator threatened to block Sanofi’s licensing deal with Maze Therapeutics, a challenge the biotech called ‘‘unprecedented.”

Licensing

Licensing Licensing Regulation Research

Type 2 Diabetes Drug Linked to 35% Lower Dementia Risk in Patients

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 11, 2024

(nomadsoulphotos/Canva) A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be at a significantly lower risk of dementia.

Drugs

Drugs Research Clinical Trials Clinical Trials

Bristol Myers’ neuroscience research head explains the big pharma’s return to brain drugs

Bio Pharma Dive

OCTOBER 27, 2023

In a wide-ranging interview, Bristol Myers’ Ken Rhodes talked biomarkers, diseases of interest and why the company is far from done with neuroscience-focused deals.

Research

Research Drugs

Psychiatry Clinical Trials: Inclusive, Patient-Centric Approaches for Mental Health Research

XTalks

DECEMBER 19, 2024

Especially as we exited the blockbuster drug period of psychiatric development and trials were failing with huge placebo effects, I think we started realizing that the patients going into trials were not the real-world patients that were getting treated with drugs in the clinic.

Clinical Trials

Clinical Trials Clinical Trials Trials Research

Roche opens new institute to advance research in human model systems

Pharmaceutical Technology

MAY 4, 2023

Roche has opened a new institute to accelerate research and development (R&D) in the area of human model systems such as organoids. Researchers at IHB will study human biology and speed up the adoption of human model systems in pharmaceutical R&D in addition to clinical practice.

Research

Research Scientist Medicine Development

Brain disease startup Neumora draws more funding for ambitious research plan

Bio Pharma Dive

OCTOBER 11, 2022

Launched last year to change how drugs for brain diseases are made, the biotech has now raised about $650 million to build a pipeline that includes two clinical-stage medicines.

Research

Research Medicine Drugs

Scientists Think This Psychedelic Drug Could Help Treat Anorexia

AuroBlog - Aurous Healthcare Clinical Trials blog

MAY 27, 2024

The psychedelic drug psilocybin (as found in ‘magic’ mushrooms) has promising potential as a treatment for the eating disorder anorexia nervosa, according to new research that looked at its effects on an animal model of the condition.

Scientist

Scientist Drugs Research Clinical Trials

This Drug Shows Potential to Stop Migraines Before They Begin

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 16, 2024

(Francesco Carta Fotografo/Moment/Getty Images) Migraines and headaches affect billions of people worldwide, and a new study suggests the drug ubrogepant can put a stop to the pain even before a migraine has fully kicked in.

Drugs

Drugs Branding Research Clinical Trials

Genentech takes up a deal to make ‘molecular glue’ drugs

Bio Pharma Dive

SEPTEMBER 20, 2023

Targeted protein degradation has emerged as one of the more competitive areas of pharmaceutical research in recent years as scientists develop new ways to reach difficult-to-drug targets.

Drugs

Drugs Protein Scientist Development

After safety setbacks, job cuts, Imara sells its top drug to a startup

Bio Pharma Dive

SEPTEMBER 8, 2022

The biotech, which has lost nearly all of its value since going public in 2020, reached a deal to sell a drug it tested in sickle cell disease to Cardurion Pharmaceuticals, a richly funded startup focused on cardiovascular research.

Drugs

Drugs Research

Common Blood Pressure Drug Increases Lifespan And Slows Aging in Animals

AuroBlog - Aurous Healthcare Clinical Trials blog

MAY 2, 2024

The hypertension drug rilmenidine has been shown to slow down aging in worms, an effect that in humans could hypothetically help us live longer and keep us healthier in our latter years. Previous research has shown rilmenidine mimics the effects of caloric restriction on a cellular level.

Drugs

Drugs Research Clinical Trials Clinical Trials

Clinical Trial Shows One Drug Performs Better Than Ozempic For Weight Loss

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 18, 2024

Patients taking Eli Lilly’s new drug Mounjaro achieved significantly greater weight loss than those on Novo Nordisk’s Ozempic, a head-to-head study published Monday showed.

Clinical Trials

Clinical Trials Clinical Trials Drugs Trials

PureTech, tweaking research, trims a ‘small number’ of positions

Bio Pharma Dive

FEBRUARY 14, 2023

The biotech company creator is deprioritizing work on a drug delivery technology called Orasome after what it described as a “key go/no go” experiment.

Drug Delivery

Drug Delivery Research Drugs

Genesis raises $200 million for AI drug discovery research

Bio Pharma Dive

AUGUST 21, 2023

The Series B round brings the total funding for Genesis, a California startup backed by Andreessen Horowitz and Nvidia’s VC arm, to over $280 million.

Research

Research Drugs

Pharmacognosy and Drug Patents: Unveiling Nature’s Medicinal Treasures

Drug Patent Watch

DECEMBER 9, 2024

In the vast realm of pharmaceutical research and development, there’s a fascinating intersection between ancient wisdom and modern science. This intersection is where pharmacognosy meets drug patents, creating a unique landscape that shapes the future of medicine. What is a Drug Patent?

Medicine

Medicine Drugs Production Development

AI-Based Drug Repurposing for Neurological Disorders: Current Status

Drug Patent Watch

APRIL 9, 2025

At the forefront of this revolution is AI-based drug repurposing. By leveraging cutting-edge technology, researchers are re-examining existing medications to identify new uses for treating conditions such as Alzheimer's, Parkinson's, and multiple sclerosis.

Drugs

Drugs Clinical Trials Clinical Trials Development

Key Considerations for Generic Drug Stability Testing

Drug Patent Watch

MARCH 12, 2025

The Unseen Heroes of Generic Drugs: Stability Testing 101 As a consumer, have you ever stopped to think about the rigorous process that goes into bringing a generic version of your favorite medication to market? For generic drug manufacturers, stability testing is a critical step in the development process.

Generic Drugs

Generic Drugs Drugs Manufacturing Branding

Roche buys into Alnylam heart drug in cardiovascular research bet

Bio Pharma Dive

JULY 24, 2023

The Swiss pharma company is the latest large drugmaker to invest big in an experimental heart treatment, after years of prioritizing medicines for cancer and immune diseases.

Pharma Companies

Pharma Companies Research Medicine Drugs

Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research

Biopharma & medical devices cos view advanced infrastructure to propel manufacturing & new drug development

Webinars

Trending Sources

NIH funds research for three experimental ALS drugs

Webinars

New research could ease concerns over suicide risk of obesity drugs

Bridging Innovation & Patient Care: The Growing Role of AI

Eisai hunts for next Alzheimer’s drug with new research pact

Odyssey recruits news investors to fund precision drug research

Upstream Bio, a richly funded startup, reveals its lead drug and research plans

AltruBio lands up to $225M after shift to immune drug research

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

As ALS research booms, one treatment center finds itself in the spotlight

Innovation in Autoimmune and Bone Health Research: Driving Progress for Better Patient Outcomes

Foundery, a new biotech venture firm, sets out to speed early immune drug research

The Great RIF(T): One FDA Division’s Destruction and What it Could Mean for Generic Drugs

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Innovating in Autoimmune and Bone Health Research: Driving Progress for Better Patient Outcomes

India takes centre-stage in clinical trials for HIV/AIDS drug

Biogen, Ionis shelve ALS drug following study failure

World Psoriasis Day 2024: New Treatments and Research Trends

Biotechs reveal layoffs, research revamps in third quarter earnings

CHARM Therapeutics secures funding for oncology drug discovery research

Novo Nordisk partners with Microsoft for AI-driven drug discovery

Understanding Challenges in Early Parkinson’s Research: Critical Insights from Dr. Tom Babic

Researchers at IISc find Pranlukast has potential applications for TB therapy

Cloud robotics labs are accelerating drug discovery and development

FDA, in another test of its flexibility, agrees to review Biogen's closely watched ALS drug

FTC, in unusual move, leads Sanofi to terminate a drug research deal

Type 2 Diabetes Drug Linked to 35% Lower Dementia Risk in Patients

Bristol Myers’ neuroscience research head explains the big pharma’s return to brain drugs

Psychiatry Clinical Trials: Inclusive, Patient-Centric Approaches for Mental Health Research

Roche opens new institute to advance research in human model systems

Brain disease startup Neumora draws more funding for ambitious research plan

Scientists Think This Psychedelic Drug Could Help Treat Anorexia

This Drug Shows Potential to Stop Migraines Before They Begin

Genentech takes up a deal to make ‘molecular glue’ drugs

After safety setbacks, job cuts, Imara sells its top drug to a startup

Common Blood Pressure Drug Increases Lifespan And Slows Aging in Animals

Clinical Trial Shows One Drug Performs Better Than Ozempic For Weight Loss

PureTech, tweaking research, trims a ‘small number’ of positions

Genesis raises $200 million for AI drug discovery research

Pharmacognosy and Drug Patents: Unveiling Nature’s Medicinal Treasures

AI-Based Drug Repurposing for Neurological Disorders: Current Status

Key Considerations for Generic Drug Stability Testing

Roche buys into Alnylam heart drug in cardiovascular research bet

Stay Connected